The next most significant signature exposure was CN-Sig-3, characterised by evenly distributed chromosome breaks and diploid-to-single copy changes (i.e., loss of heterozygosity), which in ovarian carcinoma was associated with defective homologous recombination and somatic/germline BRCA1/2 mutation27. This evidence concerns the gene BRCA1 and ovarian carcinoma.